Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Plasma β-amyloid in mild behavioural impairment – neuropsychiatric symptoms on the Alzheimer’s continuum

Ruxin Miao, Hung-Yu Chen, Sascha Gill, James Naude, View ORCID ProfileEric E. Smith, View ORCID ProfileZahinoor Ismail, for the Alzheimer’s Disease Neuroimaging Initiative
doi: https://doi.org/10.1101/2021.01.09.21249145
Ruxin Miao
aHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hung-Yu Chen
aHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
bDepartment of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sascha Gill
aHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
bDepartment of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Naude
aHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric E. Smith
aHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
bDepartment of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric E. Smith
Zahinoor Ismail
aHotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
bDepartment of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
cDepartment of Psychiatry, University of Calgary, Calgary, Alberta, Canada
dCumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zahinoor Ismail
  • For correspondence: ismailz@ucalgary.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Simple markers are required to recognize older adults at higher risk for neurodegenerative disease. Mild behavioural impairment (MBI) and plasma β-amyloid (Aβ) have been independently implicated in the development of incident cognitive decline and dementia. Here we studied the associations between MBI and plasma Aβ42/Aβ40.

Methods Participants with normal cognition (n = 86) or mild cognitive impairment (n = 53) were selected from the Alzheimer’s Disease Neuroimaging Initiative. MBI scores were derived from Neuropsychiatric Inventory items. Plasma Aβ42/Aβ40 ratios were assayed using mass spectrometry. Linear regressions were fitted to assess the association between MBI total score as well as MBI domain scores with plasma Aβ42/Aβ40.

Results Lower plasma Aβ42/Aβ40 was associated with higher MBI total score (p = 0.04) and greater affective dysregulation (p = 0.04), but not with impaired drive/motivation (p = 0.095) or impulse dyscontrol (p = 0.29) MBI domains.

Conclusion In persons with normal cognition or mild cognitive impairment, MBI was associated with low plasma Aβ42/Aβ40. Incorporating MBI into case detection can help capture preclinical and prodromal Alzheimer’s disease.

  • Alzheimer’s disease
  • mild behavioural impairment
  • beta-amyloid
  • neuropsychiatric symptoms

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Approval to access and use the present data was obtained from the ADNI database. Data collection for this study was conducted according to Good Clinical Practice guidelines, the Declaration of Helsinki, US 21CFR Part 50 - Protection of Human Subjects, and Part 56 - Institutional Review Boards, and pursuant to state and federal HIPAA regulations. Written informed consent for the study was obtained from all subjects and/or authorized representatives and study partners before protocol-specific procedures were carried out. Approval from an ethical standards committee to conduct this study was received at contributing ADNI sites.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data used in the preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu).

http://adni.loni.usc.edu/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted January 11, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Plasma β-amyloid in mild behavioural impairment – neuropsychiatric symptoms on the Alzheimer’s continuum
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Plasma β-amyloid in mild behavioural impairment – neuropsychiatric symptoms on the Alzheimer’s continuum
Ruxin Miao, Hung-Yu Chen, Sascha Gill, James Naude, Eric E. Smith, Zahinoor Ismail, for the Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2021.01.09.21249145; doi: https://doi.org/10.1101/2021.01.09.21249145
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Plasma β-amyloid in mild behavioural impairment – neuropsychiatric symptoms on the Alzheimer’s continuum
Ruxin Miao, Hung-Yu Chen, Sascha Gill, James Naude, Eric E. Smith, Zahinoor Ismail, for the Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2021.01.09.21249145; doi: https://doi.org/10.1101/2021.01.09.21249145

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (63)
  • Allergy and Immunology (145)
  • Anesthesia (47)
  • Cardiovascular Medicine (420)
  • Dentistry and Oral Medicine (74)
  • Dermatology (49)
  • Emergency Medicine (148)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (176)
  • Epidemiology (4910)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (691)
  • Geriatric Medicine (73)
  • Health Economics (193)
  • Health Informatics (637)
  • Health Policy (325)
  • Health Systems and Quality Improvement (209)
  • Hematology (87)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5416)
  • Intensive Care and Critical Care Medicine (335)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (130)
  • Occupational and Environmental Health (211)
  • Oncology (448)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (132)
  • Pediatrics (203)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (789)
  • Public and Global Health (1833)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (260)
  • Rheumatology (88)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (39)